Epilepsy

Vigabatrin versus carbamazepine monotherapy for epilepsy

Abstract Background This is an update of a Cochrane review first published in 2012 (Cochrane Database of Systematic Reviews 2012, Issue 1). The efficacy and safety of vigabatrin (VGB) as an add-on therapy for refractory epilepsy have been well established. However, this information needs to be weighed against the risk of development of visual field […]

Share

Non-pharmacological interventions for epilepsy in people with intellectual disabilities

Abstract Background Approximately 30% of patients with epilepsy remain refractory to drug treatment and continue to experience seizures whilst taking one or more antiepileptic drugs (AEDs). Several non-pharmacological interventions that may be used in conjunction with or as an alternative to AEDs are available for refractory patients. In view of the fact that seizures in […]

Share

Pharmacological interventions for epilepsy in people with intellectual disabilities

Abstract Background The prevalence of epilepsy among people with intellectual disabilities is much higher than in the general population. Seizures in this population are often complex and refractory to treatment and antiepileptic medication may have a profound effect upon behaviour (Kerr 1997). This is an updated version of a Cochrane Review first published in Issue […]

Share

Carbamazepine versus phenobarbitone monotherapy for epilepsy

Abstract Background This is an updated version of the original Cochrane review published in Issue 1, 2003, of the Cochrane Database of Systematic Reviews. Epilepsy is a common neurological condition in which abnormal electrical discharges from the brain cause recurrent unprovoked seizures. It is believed that with effective drug treatment, up to 70% of individuals […]

Share

Neuropsychological and psychological interventions for people with newly diagnosed epilepsy

Abstract Background Many people with epilepsy report experiencing psychological difficulties such as anxiety, depression and neuropsychological deficits including memory problems. Research has shown that these difficulties are often present not only for people with chronic epilepsy but also for people with newly diagnosed epilepsy. Despite this, there are very few published interventions that detail means […]

Share

Lacosamide add-on therapy for partial epilepsy

Abstract Background Around half of people with epilepsy will not achieve seizure freedom on their first antiepileptic drug; many will require add-on treatment with another drug. Sometimes multiple treatment combinations are tried to achieve maximum seizure control, although around a third of people do not achieve complete seizure control. Lacosamide is an antiepileptic drug that […]

Share

Yoga for epilepsy

Abstract Background This is an updated version of the original Cochrane review published in The Cochrane Library, Issue 1, 2002. Yoga may induce relaxation and stress reduction, and influence the electroencephalogram and the autonomic nervous system, thereby controlling seizures. Yoga would be an attractive therapeutic option for epilepsy if proved effective. Objectives To assess whether […]

Share

Propofol versus thiopental sodium for the treatment of refractory status epilepticus

Abstract Background This is an updated version of the original Cochrane review published in Issue 8, 2012. Failure to respond to antiepileptic drugs in patients with uncontrolled seizure activity such as refractory status epilepticus (RSE) has led to the use of anaesthetic drugs. Coma is induced with anaesthetic drugs to achieve complete control of seizure […]

Share

Early versus late antiepileptic drug withdrawal for people with epilepsy in remission

Abstract Background Epilepsy is a chronic neurological disorder which affects millions of people around the world. Antiepileptic drugs (AED) are the main interventions used to prevent seizures and control epilepsy. Although effective in most cases, AEDs are related to long-term adverse effects, such as cognitive and behavioural alterations. Thus when epilepsy is in remission, it […]

Share

Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child

Abstract Background Accumulating evidence suggests an association between prenatal exposure to antiepileptic drugs (AEDs) and increased risk of both physical anomalies and neurodevelopmental impairment. Neurodevelopmental impairment is characterised by either a specific deficit or a constellation of deficits across cognitive, motor and social skills and can be transient or continuous into adulthood. It is of […]

Share
  • The review abstracts published on this site are the property of John Wiley & Sons, Ltd., and of the Cochrane Review Groups that have produced the reviews.
Share
Share